Vir Biotechnology president and CEO George Scangos explains why many companies struggle to build a sustainable business model around fighting infectious diseases, particularly when it comes to developing antibiotics. However, he adds, certain therapies for viral diseases are currently more financially viable. Dr. Scangos explores why Vir decided to go “all-in” on infectious diseases, how they built a company around that mission, and how the arrival of COVID-19 impacted the young company’s trajectory.
Related
Sharon Prince,
Grace Farms Foundation
Designing From Values [Entire Talk]
A space is an expression of values, from the earliest concepts to the actual materials.
Sharon Prince,
Grace Farms Foundation
Designing From Values [Entire Talk]
A space is an expression of values, from the earliest concepts to the actual materials.
Sophia Edelstein and Nathan Kondamuri,
Pair Eyewear
From Stanford Students to Co-CEOs [Entire Talk]
Mission and culture are essential to taking a company from its earliest days to unbelievable growth.
Sophia Edelstein and Nathan Kondamuri,
Pair Eyewear
From Stanford Students to Co-CEOs [Entire Talk]
Mission and culture are essential to taking a company from its earliest days to unbelievable growth.
Clara Shih,
Salesforce.com
What No One Tells You About Entrepreneurship [Entire Talk]
Entrepreneurship is full of important decisions and unexpected paths, and it will change your life.
Clara Shih,
Salesforce.com
What No One Tells You About Entrepreneurship [Entire Talk]
Entrepreneurship is full of important decisions and unexpected paths, and it will change your life.
